Use of Collagen and HA-based Biomaterials to Be Prominent in Joint Reconstructive Surgeries: Fact.MR Report
Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Sales of collagen and HA-based biomaterials are predicted to progress at a CAGR of 6% from 2022 to 2027 and reach a market valuation of US$ 10.8 billion by 2027, reveals Fact.MR, a market research and competitive intelligence provider. The most prevalent extracellular matrix protein in the animal kingdom, collagen, is a member of the fibrous protein family that helps tissues transmit weight and gives cells a highly biocompatible environment. Collagen is the ideal biomaterial for implantable medical devices and scaffolds for in vitro testing systems due to its great biocompatibility. Mammal skin and tendons, which are rich in collagen, are rigoro
